ACTISEVEN
Live / Registered — International registration cancelled — extension of protection cancelled (as of 28 Oct 2021)
What this means for you
Registered since 11 Sept 2012. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79106488
- Registration number
- 4204192
- Mark type
- Stylized text
- Filed
- 28 Oct 2011
- Published for opposition
- 26 Jun 2012
- Registered
- 11 Sept 2012
- Attorney of record
- Jessica S. Sachs
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating coagulation disorders
- Class 042 — Scientific and technological services: Scientific and industrial research relating to hemostasis; conducting clinical trials for others relating to hemostasis
Owner
- LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES, F-91940 LES ULIS, FR
- LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES, F-91940 LES ULIS, FR
- LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES, F-91940 LES ULIS, FR
Prosecution history
- 22 May 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 22 May 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 09 Apr 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Apr 2021 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 03 Apr 2021 — CORRECTION TRANSACTION RECEIVED FROM IB
- 05 Mar 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Feb 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
- 11 Jan 2020 — GENERIC MADRID TRANSACTION SENT TO IB
- 11 Jan 2020 — GENERIC MADRID TRANSACTION CREATED
- 12 Dec 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 12 Apr 2019 — CANCELLED SECTION 71
- 11 Sept 2017 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 27 Mar 2015 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Jul 2014 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 May 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB